Hsin‑Nung Shih, MD

Articles by Hsin‑Nung Shih, MD

Although surgery and radiotherapy are standard treatments for localized STS, the role of adjuvant chemotherapy, particularly doxorubicin, in high-grade STS is debated.

Single-Agent Doxorubicin Adjuvant Chemotherapy for Resectable Grade 2/3 Soft Tissue Sarcomas: A Retrospective Study

ByShiny Chih-Hsuan Wu, MD,Yao-Yu Wu, MD,Chi-Ting Liau, MD,Chih‑Hsiang Chang, MD,Shih-Chiang Huang, MD,Hsin‑Nung Shih, MD,Chun-Chieh Chen, MD, PhD

March 26th 2026

Latest Updated Articles

Single-Agent Doxorubicin Adjuvant Chemotherapy for Resectable Grade 2/3 Soft Tissue Sarcomas: A Retrospective Study
March 26th 2026

Trending on CancerNetwork

EXCALIBER-RRMM: Iberdomide in Relapsed/Refractory Multiple Myeloma

Prioritizing Proton Therapy for Pelvic Nodal Irradiation in Prostate Cancer

Alliance A071801 Supports Fractionated SRS After Brain Metastasis Surgery

FDA OKs Pirtobrutinib in Frontline CLL/SLL

Understanding the KRAS Mutation Landscape in Biliary Tract Cancer